REACH analysis shows benefits outweigh costs

Helsinki – An analysis by the European Chemicals Agency (ECHA) has found that the benefits of authorising hazardous chemicals under the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation outweigh costs by 15 to one.

The report, ‘Socio-economic impacts of REACH authorisations’, calculates that €281 million of health risks arise each year from the continued use of chemicals that require authorisation, but that costs would be around €4.2 billion if the REACH system were not in place.

ECHA’s report was intended to look into the costs of the continued use of 20 substances of very high concern (SVHCs), finding that although risks remain high, authorisation has considerably reduced harm to the environment and individuals. The authorisation requirements for SVHCs have led to many companies substituting them with safer alternatives.

Brussels – At the request of the European Council and European Parliament, the European Commission is to devise a long-term climate…

Read Story

London - The ADVANCEFUEL project, which aims to find strategies to overcome or reduce barriers to the market up-take of advanced fuels (RESfuels),…

Read Story

Since 2017, the ADVANCEFUEL project has been exploring the social, economic, legislative and environmental barriers to the roll-out and uptake…

Read Story
Arrow-up